We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Monistat 3

ACNU Feasibility

View full report
PerfectMonistat 3 is a vaginal azole antifungal with mild side effects, low overdose and misuse risk, minimal drug interactions, and manageable special population cautions. Its short, simple 3-day suppository regimen requires proper application and follow-up if symptoms persist.

ACNU Feasibility Scorecard

Chart with 11 data points.
Monistat 3
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 2.
End of interactive chart.